News & Updates

Treatment with pyrotinib in combination with trastuzumab and docetaxel (tras/doc) results in longer progression-free survival (PFS) than placebo combined with tras/doc in patients with untreated HER2-positive metastatic breast cancer, a study has shown. In addition, the safely profile of tras/doc plus pyrotinib is manageable.

Use of machine learning (ML) can help pinpoint novel factors that contribute to an increased risk of atrial fibrillation (AF) in non-White patients with heart failure (HF), suggests a study. Specifically, social factors such as living alone may significantly heighten the AF risk.

Older women with a history of migraine need not worry too much about developing COVID-19, with a recent study suggesting that no significant association exists between migraine history and an increased risk of having COVID-19.

Subcutaneous injection of risperidone QM or Q2M (TV-46000) has been shown to significantly delay impending relapse in patients with schizophrenia in the phase III RISE study.

Patients with early-stage nonsmall cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) have similar overall survival (OS) regardless of nodal staging, reports a study. In addition, use of SBRT has shown a steady increase over the study period.

Infection with COVID-19 may increase the risk of pulmonary fibrosis, and patients with a severe disease are at greater risk of developing this complication, suggests a recent study.